期刊文献+

碳纳米材料在癌症诊疗中的应用进展 被引量:3

Application advances of carbon nanomaterial in cancer diagnosis and therapy
下载PDF
导出
摘要 癌症的早期诊断与治疗一直是关注的焦点。纳米技术的快速发展为癌症早期诊断与高效无毒的药物治疗带来新的希望。通过构建稳定、高效、低毒的药物载体,并联合抗癌药物与分子探针,可改善药物在体内的分布代谢,达到靶向运输、活体示踪的效果。碳纳米材料因其独特结构和优异性质成为药物载体研究的热点。本文就不同种类碳纳米材料在癌症诊疗中的应用进展进行综述。 Early diagnosis and treatment of cancer have always been the focus of attention. The rapid development of nanotechnology brings new hope for early diagnosis and highly effective non-toxic drug treatment of cancer. Through the construction of stable, low toxicity and high-performance carrier, which is combined with anti-cancer drugs and molecular probes to improve the distribution and metabolism of drugs in the body, targeted transport and tracer in vivo effect can achieved. Carbon nanomaterials have become a hot spot in drug carrier research with their unique structure and excellent properties. The progresses of different types of carbon nanomaterials in cancer diagnosis and treatment were reviewed in this article.
出处 《中国介入影像与治疗学》 CSCD 北大核心 2018年第2期112-115,共4页 Chinese Journal of Interventional Imaging and Therapy
基金 山西省重点研发计划项目(201703D32111144)
关键词 碳纳米材料 肿瘤 药物载体 Carbon nanomaterials Neoplasms Drug carriers
  • 相关文献

参考文献2

二级参考文献23

  • 1Livragb.i T, Solblati L, Meloni MF, et al. Treatment of focal liv- er tumors with percutaneous radio-frequency ablation: Complica- tions encountered in a multicenter study. Radiology, 2003, 226 (2) :441-451.
  • 2Narayanan G, Froud T, Suthar R, et al. Irreversible electropora- tion of hepatic malignancy. Semin Intervent Radiol, 2013,30(1) ; 67-73.
  • 3Pompili M, Mirante VG, Rondinara G, et al. Percutaneous abla- tion procedures in cirrhotic patients with hepatocellular carcinoma submitted to li'>er transplantation: Assessment of efficacy at ex- plant analysis and of safety for tumor recurrence. Liver Transpl, 2005,11(9) : 1117-1126.
  • 4Miller L, Leor J, Rubnsky B. Cancer cells ablation with irre- versible electroporation. Technol Cancer Res Treat, 2005,4(6): 699-705.
  • 5Rubinsky B, Onik G, Mikus P. Irreversible electroporation: A new ablation modality-clinical implications. Technol Cancer Res Treat, 2007,6(1) :37-48.
  • 6Mazzaferro V, Battiston C, Perrone S, e' al. Rad[ofrequency ab- lation of small hepatocellular carcinoma in cirrhotic patients awai- ting liver transplantation: A prospective study. Ann Surg, 2004, 240(5) :900-909.
  • 7Maor E, Ivorra A, Leor J, et al. The effect of irreversible elec- troporation on blood vessels. Technol Cancer Res Treat, 2007,6 (4) : 307-312.
  • 8Hester J, Marleen C, Jantien A, et al. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: A case report. Cardiovasc Intervent Radiol, 2015,38(3) : 760-765.
  • 9Zhang X, Tian JL, Zhao L, et al. CT-guided conformal cryoabla- tion for peripheral NSCLC: Initial experience. Eur J Radiol, 2012,81(11) :3354-3362.
  • 10Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversi- ble electroporation. Ann Biomed Eng, 2005,33(2):223 231.

共引文献21

同被引文献25

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部